Lantern Pharma Inc (NAS:LTRN)
$ 3.81 0.05 (1.33%) Market Cap: 41.01 Mil Enterprise Value: 7.43 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 39/100

Q3 2022 Lantern Pharma Inc. Earnings Call Transcript

Nov 07, 2022 / 09:30PM GMT
Release Date Price: $4.47 (+3.95%)
Nicole Leber
Lantern Pharma Inc. - IR Associate, Finance & Administrative Coordinator

Good afternoon, everyone. I am Nicole Leber with Investor Relations here at Lantern Pharma, and welcome to our third quarter 2022 earnings call. I will be your host for today's call. As a reminder, this call is being recorded. (Operator Instructions) A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call. We issued a press release after market close today, summarizing our financial results and the progress across the company for the third quarter of 2022. A copy of this release is available through our website at lanternpharma.com, but you will also find a link to the slides that management will be referencing on today's call.

I would like to remind everyone that remarks about future expectations, performance, estimates and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern Pharma cautions that these forward-looking statements are subject

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot